Allopurinol Tablet
Product Images NDC 71610-253

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 71610-253). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 300 mg (71610 0253 60)

Label for Allopurinol USP 300 mg oral tablets, containing 90 tablets per bottle. The label includes storage instructions, manufacturer information listing Frontida BioPharm Inc. in Philadelphia, PA, and the labeler Aphena Pharma Solutions in Cookeville, TN. The label features barcodes, NDC 71610-0253-60, lot number, expiration date, and specifies Rx only.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (Allopurinol 01)

Chemical structure of Allopurinol, depicting its molecular arrangement with nitrogen atoms in a purine-like ring and an oxygen atom double bonded to the carbon in the structure.*

FDA Label Image

Figure (Allopurinol 02)

Chemical structure diagram depicting the metabolic relationships among Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid. The diagram illustrates molecular structures and conversion pathways involving purine derivatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.